Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS20100324643 A1
Publication typeApplication
Application numberUS 12/873,389
Publication date23 Dec 2010
Filing date1 Sep 2010
Priority date6 Dec 2002
Also published asEP1596929A1, US7844347, US20040111141, WO2004052447A1
Publication number12873389, 873389, US 2010/0324643 A1, US 2010/324643 A1, US 20100324643 A1, US 20100324643A1, US 2010324643 A1, US 2010324643A1, US-A1-20100324643, US-A1-2010324643, US2010/0324643A1, US2010/324643A1, US20100324643 A1, US20100324643A1, US2010324643 A1, US2010324643A1
InventorsScott J. Brabec, Kenneth C. Gardeski
Original AssigneeMedtronic, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Medical Devices Incorporating Carbon Nanotube Material and Methods of Fabricating Same
US 20100324643 A1
The present invention relates generally to medical devices; in particular and without limitation, to unique electrodes and/or electrical lead assemblies for stimulating cardiac tissue, muscle tissue, neurological tissue, brain tissue and/or organ tissue; to electrophysiology mapping and ablation catheters for monitoring and selectively altering physiologic conduction pathways; and, wherein said electrodes, lead assemblies and catheters optionally include fluid irrigation conduit(s) for providing therapeutic and/or performance enhancing materials to adjacent biological tissue, and wherein each said device is coupled to or incorporates nanotube structures or materials therein. The present invention also provides methods for fabricating, deploying, and operating such medical devices.
Previous page
Next page
1. A method of treating a portion of biological tissue, comprising the steps:
advancing a hollow electrode member into contact with a portion of biological tissue wherein said hollow electrode member is fluidly coupled to a source of substantially biologically inert solution; and
dispensing a small amount of the substantially biologically inert solution into the contact portion between the hollow electrode member and the portion of biological tissue, wherein said substantially biologically inert solution comprises a sufficient plurality of electrically conductive nanotube structures to render the substantially biologically inert solution electrical conductive.
2. A method according to claim 1, wherein said portion of biological tissue comprises a one of the following: a cardiac tissue, a muscle tissue, an organ tissue, a brain tissue, a myocardial infarct tissue, a neurological tissue,
3. A method according to claim 1, wherein said small amount of solution is approximately about 100 microliters of solution.
4. A method according to claim 1, wherein said advancing step means piercing said portion of biological tissue and further comprising the steps:
withdrawing the hollow electrode member;
moving the hollow electrode member to an adjacent portion of biological tissue;
piercing said adjacent portion of biological tissue;
dispensing an second small amount of substantially biologically inert solution into said adjacent biological tissue.
5. A method according to claim 4, wherein said piercing step comprises at least two sub-piercing steps, a first sub-piercing step comprises the step of advancing the hollow electrode member to a first depth in said biological tissue and wherein at least a second sub-piercing step comprises advancing or retracting said hollow electrode member to a second depth different from the first depth.
6. A method according to claim 1, further comprising the steps of:
electrically coupling the hollow electrode member to a pulse generator circuit having pulse sensing capabilities;
stimulating the portion and/or the adjacent portion of biological tissue with at least one electrical pulse delivered by the hollow electrode member;
sensing a resulting evoked response from a remote electrode or from a sensor coupled to the subject.
7. A method according to claim 6, wherein said remote electrode is a one of the following: a transcutaneous electrode, a percutaneous electrode, a subcutaneous electrode, an epicardial electrode, an endocardial electrode, a pericardial electrode.
  • [0001]
    This application is a divisional application of U.S. application Ser. No. 10/403,329, filed on Mar. 31, 2003, now allowed, which claims the benefit of provisional U.S. patent application Ser. No. 60/431,330 filed Dec. 6, 2002 and entitled, “Medical Devices Incorporating Carbon Nanotube Material and Methods of Fabricating Same,” the entire contents of which are hereby incorporated by reference as if fully set forth herein.
  • [0002]
    This non-provisional patent application also incorporates the contents of co-pending non-provisional U.S. patent application Ser. No. 10/262,046 filed Oct. 2, 2002 and entitled, “Active Fluid Delivery Catheter.”
  • [0003]
    The present invention relates generally to medical devices; in particular and without limitation, to unique electrodes and/or electrical lead assemblies for stimulating cardiac tissue, muscle tissue, neurological tissue, brain tissue and/or organ tissue; to electrophysiology mapping and ablation catheters for monitoring and selectively altering physiologic conduction pathways; and, wherein said electrodes, lead assemblies and catheters optionally include fluid irrigation conduit(s) for providing therapeutic and/or performance enhancing materials to adjacent biological tissue, and wherein each said device is coupled to or incorporates nanotube structures or materials therein. The present invention also provides methods for fabricating, deploying, and operating such medical devices. For the uninitiated, to get an idea of scale—one nanometer is one one-thousandth of a micrometer; in comparison, a strand of human hair is typically 50 to 100 micrometers thick.
  • [0004]
    Even brief study of the prior art relating to medical electrical leads will reveal that such leads typically incorporate at least one electrode and the lead assembly should be compact and resilient, should yield a low threshold for stimulation, should sense the low amplitude electrical signals naturally generated by a body. In addition, such leads should be biocompatible with the adjacent body tissue and body fluids, which it contacts. Various attempts have been made to improve these characteristics, especially with respect to medical electrodes electrically coupled to the lead body of a cardiac pacing lead. Generally these attempts are aimed at increasing the interfacial, or active, surface area of an electrode by the use of surface treatments or coatings that are considered highly biocompatible.
  • [0005]
    As is known in the art, electrochemical reactions occur at the electrode-tissue interface when an electrical stimulation pulse is delivered through a medical electrical lead assembly. This phenomenon is referred to as “polarization,” which is known to interfere with efficient delivery of the stimulation pulses. High interfacial impedance due to the effects of polarization reduces the effective charge transfer of the stimulation pulse to the targeted tissue. Therefore low polarization electrodes have been developed to reduce this effect and improve the transfer of charge from the electrode to the tissue.
  • [0006]
    One method for reducing polarization effects is to increase electrode surface area. However, a design trade-off exists in increasing the electrode size since medical leads and the electrodes they carry are preferably of small dimensions such that they may be easily implanted. For example, presently available cardiac pacing leads typically have cross-sectional diameters of greater than about three or four French and a typical diameter of an electrophysiology catheter is about six French. For reference, a single French unit of measurement equals one third of a millimeter. In any event, to overcome this trade-off, methods for increasing the active surface area of a geometrically down-sized electrode have been proposed. For example, treatments or coatings that yield a porous, irregular or grooved surface increase the active surface area of the electrode and thereby diminish the effects of polarization. Various coatings have been proposed and put into commercial use for producing low polarization electrodes such as platinum black, pyrolytic carbon, iridium oxide, vitreous carbon, titanium nitride and others.
  • [0007]
    A further benefit of increasing electrode interfacial or active surface area can be improved electrode sensing performance. Cardiac signals, including action potentials that are relatively low amplitude, monophasic signals, may be more readily sensed when the active surface area of the electrode is increased. Moreover, an evoked response following delivery of a stimulation pulse may be more readily detected when post-pace polarization artifact is diminished.
  • [0008]
    Recently, as reported in the Journal of the American Chemical Society (JACS), research personnel at Washington University in St. Louis and their collaborators report that they have made boron “nanowhiskers” by chemical vapor deposition. The particles have diameters in the range of 20 to 200 nanometers and the whiskers (also called nanowires) are semiconducting and show properties of elemental boron.
  • [0009]
    The group at Washington University in St. Louis turned to boron, one spot to the left of carbon in the periodic table, to see if it would be a good candidate. They postulated that if nanotubes could be made of boron and produced in large quantities, they should have the advantage of having consistent properties despite individual variation in diameter and wall structure. The discovery that the “nanowhiskers” are semiconducting make them promising candidates for nanoscale electronic wires. Boron nitride nanotubes, which are similar in structure to carbon nanotubes, are electrically insulating. Boron nanotubes on the other hand may be grown into long thin wire-like structures. At first they appeared hollow, but after closer examination, they were determined to be dense whisker-like structures, not hollow nanotube structures. The notion of boron nanotubes creates more excitement in nanotechnology than nanowhiskers because of their unique structure, which could be likened to a distinct form of an element. Carbon, for instance, is present as graphite and diamond, and, recently discovered, in “buckyball” and nanotube conformations. Also, boron nanotubes are predicted by theory to have very high conductivity especially when bulk boron is “doped” with other atoms to increase conductivity. Carbon nanotubes also have been doped, as have various other kinds of nanowires, and assembled in combinations of conducting and semiconducting ones to make for several different microscale electronic components such as rectifiers, field-effect transistors and diodes.
  • [0010]
    The present invention is directed at providing a class of improved medical electrical lead assemblies featuring carbon nanotube material. Carbon nanotubes, discovered in about 1991, are formed from a cage-like hollow lattice structure of carbon molecules arranged into tubes having a diameter on the order of nanometers. Considerable interest in the use of carbon nanotubes in various applications such as batteries, capacitors, flat panel displays and microelectronics, has grown due to the unique properties of this newly discovered material including its high strength, stable state, low weight, and so-called ballistic (or near-superconducting) electrical properties. In addition, boron nanotubes and carbon nanotube “nanowires” are now becoming available. The inventors have discovered that these developments enable invention of discrete technologies providing significant value to patients suffering from diverse afflictions while advancing the medical device field in several important ways.
  • [0011]
    Nanotubes made exclusively from carbon are chemically inert and are therefore, the inventors suggest, are highly biocompatible. Carbon nanotubes may be formed to have metallic conductor or semi-conductor properties and are capable of sustaining a high current density, on the order of hundreds of times greater than common metals. Carbon nanotubes are thin, long tubular macromolecules with diameters on the order of a 1-200 nanometers (molecules are on the order of a few nanometers) and with lengths on the order of micrometers to millimeters. Bundles of such nanotubes create nanostructures which are characterized by a large surface area. In short, these characteristics of carbon nanotubes may make them particularly well-suited for diverse uses in conjunction with medical electrical lead assemblies and medical electrodes for improving electrode performance.
  • [0012]
    The inventors have discovered that carbon nanotubes may be adapted to render greatly improved medical electrical leads and/or medical electrodes. The present invention provides such leads and/or electrodes in one or more of the following ways. Nanotube structures coupled to, layered upon or coated upon a electrically conductive or non-conductive electrode or lead body structure. In addition, a variety of polymers and other resin-based materials when combined, encapsulated or impregnated with nanotubes can be used to render the resulting structures electrically conductive. In the context of the present invention, such structures may be configured as elongated medical lead body structures, electrode structures and the like. In addition, carbon nanotubes may be employed in lieu of a metallic coil conductor (or other type) of primary electrical conductor for all or a portion of the body of an extremely thin, resilient and flexible medical electrical lead. The resulting structure may be porous and itself impregnated with diverse materials such as steroid material, electrically conductive fluid or paste materials, and the like.
  • [0013]
    One embodiment of the present invention features a medical electrical lead carrying one or more tip-, ring-, defibrillation coil-, neurological-, brain-, skeletal muscle-, or organ-electrodes for sensing and/or delivering electrical stimulation pulses to a portion of cardiac tissue, neurological tissue, brain tissue, skeletal tissue, organ tissue and the like.
  • [0014]
    In embodiments involving cardiac tissue, the active surface area of the electrodes, which is contact with blood or bodily tissue, is increased by depositing carbon nanotubes on the electrode surface. Furthermore, carbon nanotubes at the electrode/tissue interface emit electrons from the tip portions of the nanotubes at relatively low voltages and sustain current densities hundreds of times greater than common metals. Such field emission properties can be obtained by mixing nanotubes into a composite paste with polymers such as polyurethane or silicone, applying the paste to an electrode surface, and then applying a voltage to align the nanotubes on end. Such alignment can form extremely consistent, tightly packed arrays of nanotubes or may be less consistent. In either case, a vast surface area is created which is very advantageous as is known to those of skill in the art. Such arrays of nanotubes may be impregnated with diverse materials such as biological, genetic or pharmacological substances so that over time said arrays elute the materials into adjacent tissue or body fluid. Some representative diverse materials include steroid material, electrically conductive fluid materials such as isotonic saline solution or other biologically compatible fluids.
  • [0015]
    In another embodiment, a carbon nanotube coating may be applied to a metallic electrode substrate, such as platinum, platinum-iridium, titanium, alloys of the foregoing and other metals by chemical vapor deposition or other methods known in the art for growing and depositing carbon nanotubes on a substrate. The surface area of the carbon nanotubes, which may include the outer surface and the inner surface of the tubes, effectively increases the active electrode surface area of the metallic electrode substrate.
  • [0016]
    The carbon nanotube coating provides a highly biocompatible electrode surface. Moreover, the carbon nanotube coating provides a low electrode-tissue interface impedance allowing for improved sensing of low frequency, intrinsic cardiac signals as well as evoked responses from cardiac tissue. The high-energy density properties of carbon nanotubes further provides lower stimulation thresholds for capturing a heart during pacing and/or when delivering defibrillation therapy to a heart.
  • [0017]
    While chemical vapor deposition (CVD) represents one manner of mass producing apparatus according to the present invention, CVD generally has a higher density of structural defects and a subsequently a larger variation in resistivity. Metallic catalysts such as nickel, iron, cobalt, molybdenum and ruthenium are usually necessary for formation of consistent, high yield films using CVD. Achieving good contact resistances to the substrate material is still a matter of adapting the catalyst and substrate to one another, among other variables. If the formation of thin oxide layers, on the atomic scale, occur between the nanotubes and metal substrate, high ohmic-contact resistance is often the result. As research continues with respect to high yield, mass production of carbon nanotube coatings, there are now presently available highly ordered single-wall and multi-wall nanotube structures on substrates in a very ordered manner.
  • [0018]
    In this patent disclosure the term “nanotube(s)” is intended to refer to nanostructures in general; that is, substantially one dimensional so-called nanowires (or “nanowhiskers”), two dimensional, substantially planar structures such as fullerenes (e.g., a convex cage of atoms with only hexagonal and/or pentagonal faces) having a cylindrical shape, and three-dimensional structures such as the so-called buckyballs, closed- and open-ended nanotubes, and the like. The inventors suggest that when incorporated into suitably adapted structures the fully variety of nanostructures may be used to improve the electrical performance of myriad medical electrical leads. In some applications, the nanostructures may also be used to retain and/or release over time the above-noted diverse materials, such as electrically conductive fluids, biological, genetic and/or pharmacological substances. Thus, the terms used in the present patent disclosure may differ from the evolving convention(s) for referring to a broad variety of different nano-scale structures. For example, typically, a nanotube is any tube having nanoscale dimensions, but is often intended to generally refer to carbon nanotubes. In this disclosure the reverse is true. Thus, in this disclosure “nanotube” or “nanostructure” is intended to include carbon nanotubes and other nanostructures, and shall also be deemed to cover a often mentioned non-carbon variety of nanotube made of boron and the like. In general, then, nanotubes are sheets of graphite rolled up to make a tube. The dimensions are variable (down to 0.4 nm in diameter) and a single nanotube can be formed or disposed within another nanotube, leading to a distinction between multi-walled and single-walled nanotubes (“MWNT” and “SWNT,” respectively).
  • [0019]
    Apart from remarkable tensile strength, nanotubes exhibit varying electrical properties (depending on the way the graphite structure spirals around the tube, and other factors), and can be insulating, semiconducting or conducting (metallic).
  • [0020]
    Nanotubes can be either electrically conductive or semiconductive, depending on their helicity, leading to nanoscale wires and electrical components. These one-dimensional fibers exhibit electrical conductivity as high as copper, thermal conductivity as high as diamond, strength 100 times greater than steel at one sixth the weight, and high strain to failure.
  • [0021]
    Carbon nanotubes exhibit extraordinary mechanical properties: the Young's modulus is over 1 Tera Pascal and as stiff as diamond with an estimated tensile strength of about 200 Giga Pascal. These properties are ideal for reinforced composites and nanoelectromechanical systems, among others.
  • [0022]
    Carbon nanotube transistors exploit the fact that nm-scale nanotubes are ready-made molecular wires and can be rendered into a conducting, semiconducting, or insulating state, which make them valuable for future nanocomputer design. Carbon nanotubes are quite popular now for their prospective electrical, thermal, and even selective-chemistry applications.
  • [0023]
    While the present invention will be described primarily with reference to single- and multi-walled carbon nanotubes (SWNT/MWNT), it is not to be construed as being limited solely to such materials. For example, the present invention may be practiced using so-called “nanowires” or “nanowhiskers” (NW). Such NW may be produced of carbon or other related elements such as boron and the NW (and SWNT/MWNT) may be doped or modified so they readily conduct electricity, are semi-conductive, or even insulative.
  • [0024]
    The foregoing summary is intended to briefly introduce the reader to the basic concepts of the present invention and should not be construed as limiting the invention hereof. Likewise, the following drawings (and those incorporated herein) are illustrative of only a few embodiments of the present invention, are not drawn to scale and should not be viewed as limiting the scope of the present invention. In fact, those of skill in the art will quickly recognize variations of the described and depicted embodiments of the present invention, and each such variation is intended to be covered by this patent disclosure.
  • [0025]
    FIG. 1A is a plan view of a cardiac pacing lead that may be used in conjunction with the present invention. It should be noted that the pacing lead may have one or more anode rings.
  • [0026]
    FIG. 1B is a plan view of the distal end of a cardiac pacing and defibrillation lead that may be used in conjunction with the present invention.
  • [0027]
    FIG. 2 is a flow diagram summarizing a method for manufacturing a carbon nanotube coated medical electrode.
  • [0028]
    FIG. 3 is an illustration of a magnified, side view of a carbon nanotube coated electrode wherein the nanotubes are aligned.
  • [0029]
    FIG. 4 is an illustration of a magnified, side view of a carbon nanotube coated electrode wherein the nanotubes are randomly ordered.
  • [0030]
    FIG. 5 is an illustration of a magnified, side view of a carbon nanotube coated electrode wherein the nanotubes are coiled and randomly arranged.
  • [0031]
    FIG. 6 is a flow chart summarizing an alternative method for manufacturing a carbon nanotube coated medical electrode.
  • [0032]
    As described above, the present invention is directed at providing a medical lead having improved electrode performance by providing carbon nanotube coated electrodes. FIGS. 1A and 1B depict exemplary medical leads of the type that may be used with the present invention. FIG. 1A is a plan view of a medical lead 10 that may typically be used for cardiac pacing and/or sensing. Lead 10 is provided with an elongated lead body 12, a helical tip electrode 14 located at the distal end of the lead and a ring electrode 16 spaced proximally from tip electrode 14. A connector assembly 18 at the proximal end of lead 10 is used to connect the lead to a medical device, such as a pacemaker. Conductors extending the length of lead body 12 electrically couple the tip electrode 14 and ring electrode 16 to respective connectors carried by the connector assembly 18.
  • [0033]
    FIG. 1B is a plan view of the distal end of a medical lead 20 of the type that may be used for pacing, sensing, cardioversion and/or defibrillation. Lead 20 is provided with a tip electrode 22 and a ring electrode 24, which are generally used for pacing and/or sensing, and two defibrillation coil electrodes 26 and 28 for delivering high-energy shocking pulses for cardioversion or defibrillation.
  • [0034]
    The exemplary leads 10 and 20 of FIGS. 1A and 1B are shown to illustrate the various types of electrodes, including ring electrodes (16 and 24), coil electrodes (26 and 28), helical electrodes (14), or generally hemispherical electrodes (22), with which the present invention may be used. Other electrodes of various geometries may exist that may also benefit from the use of carbon nanotube coating as provided by the present invention. The application of the present invention is therefore not limited to the types of electrodes depicted in FIGS. 1A and 1B. The present invention may also be used in conjunction with electrodes for neurological stimulation or sensing, smooth or skeletal muscle sensing or stimulation or any other types of medical electrodes that may benefit from increased active surface area and/or increased current density capacity.
  • [0035]
    An electrode used with the present invention is preferably fabricated from a conductive biocompatible material appropriate for depositing carbon nanotubes thereto. CVD methods begin with supported catalyst particles that are exposed to a carbon feedstock gas (e.g., acetylene or methane). Carbon atoms from the dissociation of these molecules at the catalyst surface dissolve in the catalyst particles to reappear on the surface, where they organize to form nanotubes. Depending on the growth conditions (e.g. gas mixture, gas flows, reaction temperature, reaction time, and catalyst), the catalyst particle either remains on the surface (base growth) or is lifted from the surface by the nanotube (tip growth).
  • [0036]
    As mentioned earlier, adapting the catalyst to the substrate is critically important and note that catalysts can also be deposited to the substrate surface before introducing the carbon nanotubes. Noble metal substrates such as gold are known to suppress growth. The problem is most likely due to alloy formation with the catalyst material. Refractory metals and their nitrides can act as a diffusion barrier to the chosen catalyst. Also, applying an AC or DC electric field helps in nanotube growth.
  • [0037]
    The electrode material may be, for example, platinum, platinum-iridium, iridium, titanium or alloys , tantalum, and other non-noble metals. The electrode surface may also be treated or coated to enhance the surface for nanotube deposition, as will be further described below.
  • [0038]
    Carbon nanotubes may be grown and deposited onto a surface by at least three methods: 1) chemical vapor deposition, 2) carbon arc deposition, and 3) laser evaporation deposition. Chemical vapor deposition methods generally use a metal catalyst substrate at a high temperature to which a hydrocarbon gas is exposed. Carbon nanotubes are deposited on the catalyst surface and may be grown in various structures such as straight tubes that may be well-aligned or coiled tubes. A method for growing densely packed, uniform nanotube arrays perpendicular to a substrate is generally disclosed in U.S. Pat. No. 6,361,861 issued to Gao et al., incorporated herein by reference in its entirety.
  • [0039]
    Carbon arc deposition methods include evaporating material from a graphite electrode in an electric arc discharge between two graphite electrodes. Carbon nanotubes deposit on the other graphite electrode and are generally straight but may be impure with a high percentage of nanoparticles. Laser evaporation techniques involve forming carbon nanotubes in a plume of carbon vapor evaporated from a graphite target by a laser at high temperature.
  • [0040]
    Methods for growing and depositing carbon nanotubes on a substrate may produce varying purity, density, alignment, structure, and size of the nanotubes. Carbon nanotubes are formed as one or more concentric shells of graphite and therefore may be single-walled, double-walled or multi-walled tubes. Nanotubes may be straight or may have irregular curving or coiling shapes. Nanotubes reportedly range in diameter from 1 nanometer to several hundred nanometers. Nanotubes may be grown to be on the order of 1 micron to several hundred microns in length. Future methods for carbon nanotube growth and deposition may be developed that improve the purity, increase uniformity or achieve desired geometries or properties of the nanotubes, such as desired electrical properties.
  • [0041]
    In the present state of the art, carbon nanotube coated electrodes are contemplated to be produced by chemical vapor deposition methods, though any of the above described methods or modifications thereof or newly developed methods may be used. FIG. 2 is a flow chart depicting one method for producing a carbon nanotube coated electrode. The method may begin by preparing an electrode surface for deposition of the carbon nanotubes at step 102. The electrode is preferably fabricated from platinum or platinum-iridium. The electrode may take the form of any known types of electrodes, such as those shown in FIGS. 1A and 1B. The platinum iridium surface of the electrode may be a sufficient catalyst for carbon deposition. Alternatively, the electrode surface may be prepared by creating a more porous surface and/or coating the surface with an alternative biocompatible catalyst to promote strong bonding of the carbon nanotubes to the electrode surface or to enhance the deposition process. For example, a platinum electrode may be coated with a porous coating of catalytic nanoparticles. The porous coating may provide a better catalyst for carbon nanotube deposition in that the growth direction, size, and density of the nanotubes may be controlled by the pores (see Li et al., Science, 1996;274(5239):1701-3.
  • [0042]
    The electrode may then be mounted in a vacuum chamber at step 104 through which an inert gas flows, such as a helium-argon gas, to raise the pressure in the chamber at step 106. The temperature of the substrate is raised at step 108. The temperature may typically be raised to a level on the order of 500 to 1000 degrees C. Resistive heating elements may be used to heat the substrate, although other equivalent means may be employed.
  • [0043]
    A carbon source in the form of a hydrocarbon gas, which may be, for example, acetylene gas, methylene gas, or ethylene gas, is then allowed to flow through the chamber at step 110. At step 112, nanotube deposition and growth are allowed to occur. The time required for adequately coating the electrode surface with a carbon nanotube coating may range from several minutes to several hours. The size of the nanotubes and their uniformity and density may be controlled by the flow rate of the hydrocarbon gas, the temperature of the substrate, the density of the catalyst on the substrate or other conditions.
  • [0044]
    Verification of the carbon nanotube coating may be performed by scanning electron microscopy or other methods at step 114. Verification may be performed to ensure a desired density or size of the nanotubes has been achieved or to ensure that the nanotubes are well attached to the electrode surface. The carbon nanotube coated electrode may then be assembled onto a lead at step 116 and electrically coupled to a conductor extending through the lead body.
  • [0045]
    Nanotubes may be deposited in an orderly, aligned fashion using various deposition methods. FIG. 3 is an illustration of a side view of an ordered nanotube “forest” 30 as it may be deposited on the surface of an electrode 32. The nanotube “forest” 30 may be grown such that the nanotubes are well aligned with one another and each generally have one end attached to the electrode surface. The nanotubes may be on the order of 0.1 to 300 microns in length and one to 200 nanometers in diameter depending on the deposition method used. A preferred range of diameters is in the range of approximately about one nm to about 20 nm but the present invention is not to be strictly limited to this range. In certain embodiments of the present invention a highly ordered array of SWNT members disposed approximately perpendicular to a supporting member having a diameter dimension on the order of approximately about one to about five nm diameters. But that does not mean an excellent electrode couldn't be had with random MWNT's about 200 nm diameter in a urethane paste and the like.
  • [0046]
    FIG. 4 illustrates an alternative arrangement of deposited nanotubes on a medical electrode surface. Nanotubes 36 may be deposited in a disorderly fashion wherein nanotubes 36 are straight but not aligned with respect to each other. The tubes will still have one end generally attached to the electrode surface 38.
  • [0047]
    FIG. 5 illustrates yet another arrangement of deposited nanotubes 40 on a medical electrode surface 42. In this embodiment, coiled nanotubes 40, having one end attached to the electrode surface 42, are arranged randomly on electrode surface 42. Deposition methods resulting in coiled nanotubes have been described previously in the prior art.
  • [0048]
    The paste method described earlier is a preferred manner of coupling nanostructures to chronically implanted medical devices. In an alternative embodiment, carbon nanotubes may be grown and purified in a first process and then deposited onto an electrode surface as a coating in a second process. A method for depositing a purified carbon nanotube material onto a conductive substrate is generally disclosed in U.S. Pat. No. 6,280,697 issued to Zhou et al., incorporated herein by reference in its entirety.
  • [0049]
    FIG. 6 is a flow chart summarizing this alternative method for manufacturing carbon nanotube coated electrodes. Carbon nanotubes are grown at step 122 and purified at step 124. For example, carbon nanotubes may be formed by arc or laser deposition methods, or any known method, and purified by an appropriate method such as filtering through a microporous membrane. Alternatively, carbon nanotube materials that may be suitable for coating medical electrodes may be obtained directly from commercial sources such as NanoLab, Brighton, Mass.; CarboLex, Lexington, Ky.; Materials and Electrochemical Research Corporation, Tucson, Ariz., among a growing number of other suppliers.
  • [0050]
    At step 126, the nanotubes are suspended in a solvent, such as alcohol. An electrode to be coated may then be placed in a vessel with the suspension of carbon nanotubes at step 128. The solvent is then driven off at step 130 leaving a coating of nanotubes on the surface of the electrode. The nanotube coating may be verified at step 132 as described above. The electrode may then be assembled onto a medical lead at step 134.
  • [0051]
    The increase in active surface area created by a carbon nanotube coating is expected to be a minimum of 1,000 to potentially on the order of about 10,000. This increase is theorized to result in a reduction in interfacial impedance at low frequencies from approximately 1000, associated with prior known electrode coating methods such as sputtered porous titanium nitride, and iridium oxide. That is, the increase in active surface area created by a carbon nanotube coating is expected to be on the order off 1,000 to about 10,000. The low frequencies referred to hereinabove, are on the order of less than about 0.1 Hz (or lower). Such a decrease in interfacial impedance improves electrode sensing performance which is very important for certain medical applications, such as cardiac rhythm management. This reduction in interfacial impedance and the high current density properties of carbon nanotubes also reduces pacing and/or defibrillation thresholds.
  • [0052]
    Methods for increasing the defects in the walls of the deposited nanotubes or for opening the ends of the tubes may be used to further increase the active surface area of the electrode. For example mechanical ball-milling or exposure to ultrasonic energy as generally disclosed in U.S. Pat. No. 6,280,697 may be applied to increase the available, accessible surface area. Theoretically, by creating more openings in the nanotubes, electrolytes may enter the tubes, which would expectedly further reduce the interfacial impedance, improving the electrode performance.
  • [0053]
    An improved medical lead having carbon nanotube coated electrodes and method for manufacture provided by the present invention has been described according to specific embodiments. It is recognized that one knowledgeable in the art may conceive variations of these embodiments that generally gain the benefits provided by a carbon nanotube coated electrode. The above described embodiments should therefore not be considered limiting in regard to the following claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4649934 *7 Jun 198517 Mar 1987Faro Medical Technologies, Inc.Joint laxity measurement
US4679572 *11 Mar 198614 Jul 1987Intermedics, Inc.Low threshold cardiac pacing electrodes
US5074313 *20 Apr 199024 Dec 1991Cardiac Pacemakers, Inc.Porous electrode with enhanced reactive surface
US5097543 *3 Dec 199024 Mar 1992Waterline Products Co. Ltd.Shower door
US5097843 *10 Apr 199024 Mar 1992Siemens-Pacesetter, Inc.Porous electrode for a pacemaker
US5324325 *29 Mar 199328 Jun 1994Siemens Pacesetter, Inc.Myocardial steroid releasing lead
US5326448 *15 Oct 19925 Jul 1994Telectronics Pacing Systems, Inc.Method for reducing the polarization of bioelectrical stimulation leads using surface enhancement, and product made thereby
US5431649 *27 Aug 199311 Jul 1995Medtronic, Inc.Method and apparatus for R-F ablation
US5571158 *6 Aug 19925 Nov 1996Biotronik Mess- Und Therapiegeraete Gmbh & Co. Ingenieurbuero BerlinStimulation Electrode
US5609622 *12 Dec 199511 Mar 1997W. L. Gore & Associates, Inc.Implantable electrode with conductive polytetrafluoroethylene elecrode
US5636276 *18 Apr 19953 Jun 1997Brugger; RolfDevice for the distribution of music information in digital form
US5639276 *23 Sep 199417 Jun 1997Rapid Development Systems, Inc.Device for use in right ventricular placement and method for using same
US6031711 *15 May 199729 Feb 2000Hyperion Catalysis International, Inc.Graphitic nanofibers in electrochemical capacitors
US6099524 *28 Jan 19948 Aug 2000Cardiac Pacemakers, Inc.Electrophysiological mapping and ablation catheter and method
US6240320 *5 Jun 199829 May 2001Intermedics Inc.Cardiac lead with zone insulated electrodes
US6265466 *12 Feb 199924 Jul 2001Eikos, Inc.Electromagnetic shielding composite comprising nanotubes
US6273875 *17 Aug 199814 Aug 2001Edwards Lifesciences CorporationMedical devices having improved antimicrobial/antithrombogenic properties
US6280697 *1 Mar 199928 Aug 2001The University Of North Carolina-Chapel HillNanotube-based high energy material and method
US6311088 *13 Apr 199930 Oct 2001Medtronic, Inc.Dual-chamber pacemaker with optimized PVARP following event that may disrupt AV synchrony
US6361861 *14 Jun 199926 Mar 2002Battelle Memorial InstituteCarbon nanotubes on a substrate
US6434430 *9 May 200113 Aug 2002Medtronic, Inc.Co-extruded, multi-lumen medical lead
US6576341 *9 Apr 199910 Jun 2003Horcom LimitedComposition
US6743463 *28 Mar 20021 Jun 2004Scimed Life Systems, Inc.Method for spray-coating a medical device having a tubular wall such as a stent
US6999821 *18 Jan 200214 Feb 2006Pacesetter, Inc.Body implantable lead including one or more conductive polymer electrodes and methods for fabricating same
US20030077515 *2 Apr 200124 Apr 2003Chen George ZhengConducting polymer-carbon nanotube composite materials and their uses
US20040064174 *27 Sep 20021 Apr 2004Belden Elisabeth L.Methods and apparatus for joining small diameter conductors within medical electrical leads
US20050075708 *21 Nov 20037 Apr 2005O'brien Robert C.Nanotube coatings for implantable electrodes
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US20100125319 *9 Oct 200920 May 2010Torsten ScheuermannCell-repelling polymeric electrode having a structured surface
US20120319705 *23 Feb 201120 Dec 2012Technische Universitat IlmenauHybrid three-dimensional sensor array, in particular for measuring electrogenic cell assemblies, and the measuring assembly
U.S. Classification607/121, 607/116
International ClassificationA61N1/05
Cooperative ClassificationA61N1/056, A61N1/0556, A61N1/0565
European ClassificationA61N1/05N2, A61N1/05N, A61N1/05L4
Legal Events
29 Sep 2010ASAssignment
Effective date: 20030723